| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
844 |
412 |
$53K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
631 |
298 |
$27K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
317 |
185 |
$26K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
90 |
49 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,719 |
1,536 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
800 |
738 |
$4K |
| 80053 |
Comprehensive metabolic panel |
1,579 |
1,448 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
74 |
67 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
83 |
66 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,238 |
1,116 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
143 |
70 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
139 |
134 |
$505.58 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
12 |
$414.93 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
450 |
32 |
$271.70 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
99 |
96 |
$181.53 |
| 87481 |
|
179 |
20 |
$148.20 |
| 87640 |
|
39 |
20 |
$123.50 |
| 87653 |
|
39 |
20 |
$123.50 |
| 81001 |
|
206 |
197 |
$118.14 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
12 |
12 |
$89.05 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
39 |
20 |
$49.39 |
| 71045 |
Radiologic examination, chest; single view |
45 |
38 |
$44.18 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
29 |
27 |
$41.72 |
| 80061 |
Lipid panel |
12 |
12 |
$37.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
25 |
25 |
$3.48 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
308 |
291 |
$1.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
192 |
171 |
$0.00 |
| A9270 |
Non-covered item or service |
768 |
539 |
$0.00 |
| J3490 |
Unclassified drugs |
133 |
76 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14 |
12 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
42 |
15 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
14 |
12 |
$0.00 |